The ability of ALG@dECM to promote angiogenesis, regulate macrophage behavior, and potentially activate ANGPTL4‐mediated metabolic regulation further validates the importance of hydrogel‐based ECM in treating myocardial infarction. Here, ANGPTL4 is linked to myocardial infarction.